Bharat Biotech’s intranasal COVID-19 vaccine to cost ₹800 for private markets
Image for representational purposes only. | Photo Credit: The Hindu Hyderabad-based Bharath Biotech said Tuesday that its nasally administered vaccine, iNCOVACC, would be available for public use from the fourth week of January and cost ₹800 for private markets and ₹325 for governments. iNCOVACC will be rolled out as a booster dose for those above […]
Continue Reading
